for info Ritter Pharmaceuticals Inc (NASDAQ:RT
Post# of 658
Quote:
Ritter Pharmaceuticals Inc (NASDAQ:RTTR) shares are almost 13% in the green on Wednesday as the company’s bull run continues. Traders have been piling into the nano-cap this week after the company issued a press release on Monday announcing that it has concluded the last patient visit in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance. Top-line results are expected to be announced in the first quarter of next year. If approved, the drug would be the first FDA-approved drug for lactose intolerance, a condition that afflicts a number of people (although to varying degrees). Three funds from our database were long Ritter Pharmaceuticals Inc (NASDAQ:RTTR) at the end of the second quarter, unchanged from the previous quarter.
I know here there is a lot PPl on lactose intolerance ()some in my familly) ... hope it will get the ok
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone